Language Select
Varian Logo

Press Releases

July 26, 2017
Varian Medical Systems (NYSE:VAR), the world's leading manufacturer of medical devices and software for treating and managing cancer, today announced its third-quarter fiscal 2017 operating... Read more
July 25, 2017
Varian Medical Systems (NYSE: VAR) today announced it will be showcasing its latest radiotherapy and radiosurgery technologies and software July 30 – August 3 in Denver at the 2017 American... Read more
July 18, 2017
Varian Medical Systems (NYSE: VAR) announced today that radiation oncology professionals using its Eclipse™ treatment planning software created the top scoring head and neck cancer treatment... Read more
July 11, 2017
A 68-year-old breast cancer patient has become the first person in the nation of Georgia to be treated using the Edge™ radiosurgery system from Varian Medical Systems (NYSE: VAR) in combination... Read more
June 29, 2017
Varian Medical Systems (NYSE: VAR) has received FDA 510(k) clearance for its Halcyon™ system, its new device for cancer treatment. Halcyon simplifies and enhances virtually every aspect of... Read more
June 26, 2017
Varian Medical Systems (NYSE: VAR) announced today that it will report results for the third quarter of fiscal year 2017 following the close of regular trading on Wednesday, July 26, 2017. The... Read more
June 22, 2017
A significant milestone for the UK's first National Health Service high energy proton therapy center occurred today when Varian Medical Systems (NYSE: VAR) delivered the cyclotron to the new... Read more
June 21, 2017
In the first project of its kind outside the United States, Varian Medical Systems (NYSE: VAR) is working with Sify Technologies to provide software-as-a-service (SaaS) to radiotherapy centers... Read more
June 20, 2017
Varian Medical Systems (NYSE: VAR) announced it has successfully installed a Varian ProBeam cyclotron at the National Centre for Particle Therapy in Aarhus, Denmark. The installation of the... Read more
June 15, 2017
Varian Medical Systems (NYSE: VAR) is spotlighting its new Halcyon™ radiotherapy treatment system at the 2017 meeting of DEGRO, the German radiation oncology society, which takes place in Berlin... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
VP, Investor Relations
650.424.5163
[email protected]